![]() |
Volumn 34, Issue 5, 2002, Pages 1661-1662
|
Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: Singles-center experience
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
DIABETES MELLITUS;
DOSE RESPONSE;
GRAFT SURVIVAL;
HEMOPHAGOCYTIC SYNDROME;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
SUICIDE;
TREATMENT OUTCOME;
VIRUS INFECTION;
ADULT;
ARTICLE;
CLASSIFICATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CYTOMEGALIC INCLUSION BODY DISEASE;
DRUG COMBINATION;
FEMALE;
GRAFT REJECTION;
HISTOCOMPATIBILITY TEST;
IMMUNOLOGY;
MALE;
POSTOPERATIVE COMPLICATION;
TREATMENT FAILURE;
ADULT;
COMPARATIVE STUDY;
CYCLOSPORINE;
CYTOMEGALOVIRUS INFECTIONS;
DIABETES MELLITUS;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HISTOCOMPATIBILITY TESTING;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
MALE;
POSTOPERATIVE COMPLICATIONS;
TACROLIMUS;
TREATMENT FAILURE;
HUMANS;
|
EID: 0035993686
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02970-6 Document Type: Conference Paper |
Times cited : (2)
|
References (7)
|